Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
Critical Reviews in Oncology/Hematology|April 24, 2025
Review of the contribution of clinical and genetic factors to the racial disparity in taxane-induced peripheral neuropathyNam Nguyen-Hoang, Maisa Nazzal, Bryan P Schneider, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 28, 2026
Importance of and Strategies for Implementing DPYD Testing to Prevent Severe Fluoropyrimidine Chemotherapy Toxicity in Health Care SystemsJeremy Kratz, Karen Merritt, Jessica Jorgensen, et al.
Physiological Genomics|September 10, 2017
Germline genetic variants with implications for disease risk and therapeutic outcomesAmy L Pasternak, Kristen M Ward, Jasmine A Luzum, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2021
Neuropathy severity at the time of oxaliplatin treatment alteration in patients with colon cancer (Alliance A151912)Daniel L Hertz, Travis J Dockter, Daniel V Satele, et al.
Clinical Pharmacology and Therapeutics|May 27, 2021
Analysis Approaches to Identify Pharmacogenetic Associations With PharmacodynamicsDaniel L Hertz, Laura B Ramsey, Mathangi Gopalakrishnan, et al.
BMC Cancer|November 24, 2018
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trialsLauren A Marcath, Taylor D Coe, Emily K Hoylman, et al.
Clinical Pharmacology and Therapeutics|June 23, 2023
Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine ChemotherapyDaniel L Hertz, D Max Smith, Stuart A Scott, et al.
Computational Toxicology (Amsterdam, Netherlands)|February 12, 2019
Homology models of mouse and rat estrogen receptor-α ligand-binding domain created by in silico mutagenesis of a human template: molecular docking with 17ß-estradiol, diethylstilbestrol, and paraben analogsThomas L Gonzalez, James M Rae, Justin A Colacino, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2021
Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variabilityLi Chen, Ciao-Sin Chen, Yihan Sun, et al.
Clinical Pharmacology and Therapeutics|April 21, 2021
Planning and Conducting a Pharmacogenetics Association StudyDaniel L Hertz, Meghan J Arwood, Gabriele Stocco, et al.
Pageof 22